戻る Agenda
Keynote Address(es)
Session Chair(s)
Dionne Price, PhD
Deputy Director, Office of Biostatistics, OTS, CDER
FDA, United States
Speaker(s)
Session Co-Chair
Jerald Schindler, DrPH
Strategic Statistics, United States
Chief Executive Officer
The 21st Century Vision for New Drug Review at CDER and the Role of Statisticians
Janet Woodcock, MD
United States
Retired, Principal Deputy Commissioner, FDA
The Times They Are A-Changin': How Economic Demands and Drug Development Challenges are Altering the Face of Pharmaceutical R&D
Kenneth I. Kaitin, PhD
Tufts Center for the Study of Drug Development, United States
Professor and Senior Fellow